← Leaderboards
David A. Leib
Dartmouth College
$22,334,432
Attributed
$23,518,025
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,518,025 · 10
By mechanism
R01$16,026,725 · 3
P01$5,930,433 · 3
R21$902,000 · 2
R03$459,000 · 1
P20$199,867 · 1
Top collaborators
- Margaret E Ackerman3 shared
Most similar at Dartmouth College
Same institution · by research overlap
- Michael Joseph Ragusa$3,930,720
- Aaron Barchowsky$9,215,155
- Amy E Keating$19,695,788
- Ta-Yuan Chang$17,233,174
- Sharon Elizabeth Bickel$6,606,592
Others in their field
Top investigators on “Gene Expression”
- Jeffrey P Krischer · University Of South Florida$137,481,663
- Eric S Lander · Whitehead Institute For Biomedical Res$128,154,716
- Stacey Gabriel · Massachusetts Institute Of Technology$86,302,566
- Bruce W Stillman · Cold Spring Harbor Laboratory$82,324,317
- Michael P Snyder · Yale University$75,701,723
- Ronald G Crystal · Weill Medical College Of Cornell Univ$74,774,977
Research focus
Gene ExpressionSimplexvirusVirusViralHerpesviridaeNeuronsInterferonsInfectionGenesPathogenNatural ImmunityVirus DiseasesPathogenesisSiteAutophagocytosisPathway InteractionsPreventionHerpes LabialisNeurotropicKeratitisVirus ReplicationLife Cycle StagesResistanceViral Genes
Grant awards (65)
Understanding and optimizing antibody-based interventions against neonatal HSV infection$780,611
R01 · FY2025 · AI
Viral and Host Factors in Herpetic Diseases$410,000
R01 · FY2025 · EY · contact PI
Understanding and optimizing antibody-based interventions against neonatal HSV infection$785,011
R01 · FY2024 · AI
Viral and Host Factors in Herpetic Diseases$410,000
R01 · FY2024 · EY · contact PI
Does Antibody-Dependent Intracellular Neutralization Limit HSV-1 Reactivation?$246,000
R21 · FY2024 · AI · contact PI
Viral and Host Factors in Herpetic Diseases$61,065
R01 · FY2024 · EY · contact PI
Viral and Host Factors in Herpetic Diseases$60,879
R01 · FY2024 · EY · contact PI
Understanding and optimizing antibody-based interventions against neonatal HSV infection$801,565
R01 · FY2023 · AI
Project 3 - Innate immunity and the HSV lytic/latent balance$588,600
P01 · FY2023 · AI · contact PI
Viral and Host Factors in Herpetic Diseases$410,000
R01 · FY2023 · EY · contact PI
Does Antibody-Dependent Intracellular Neutralization Limit HSV-1 Reactivation?$205,000
R21 · FY2023 · AI · contact PI
Project 3 - Innate immunity and the HSV lytic/latent balance$549,626
P01 · FY2022 · AI · contact PI
Viral and Host Factors in Herpetic Diseases$462,000
R01 · FY2022 · EY · contact PI
Project 3 - Innate immunity and the HSV lytic/latent balance$578,920
P01 · FY2021 · AI · contact PI
Viral and Host Factors in Herpetic Reactivation$392,850
R01 · FY2021 · EY · contact PI
Project 3 - Innate immunity and the HSV lytic/latent balance$590,400
P01 · FY2020 · AI · contact PI
Viral and Host Factors in Herpetic Reactivation$506,000
R01 · FY2020 · EY · contact PI
Monoclonal antibody therapy for neonatal HSV infections$205,000
R21 · FY2020 · AI · contact PI
Project 3 - Innate immunity and the HSV lytic/latent balance$607,775
P01 · FY2019 · AI · contact PI
Viral and Host Factors in Herpetic Reactivation$526,522
R01 · FY2019 · EY · contact PI
Monoclonal antibody therapy for neonatal HSV infections$246,000
R21 · FY2019 · AI · contact PI
Viral and Host Factors in Herpetic Reactivation$405,000
R01 · FY2018 · EY · contact PI
Viral and Host Factors in Herpetic Reactivation$47,191
R01 · FY2018 · EY · contact PI
Viral and Host Factors in Herpetic Reactivation$47,191
R01 · FY2018 · EY · contact PI
Innate Immunity and the HSV lytic/latent balance$485,998
P01 · FY2017 · AI · contact PI
Viral and Host Factors in Herpetic Reactivation$405,000
R01 · FY2017 · EY · contact PI
Innate Immunity and the HSV lytic/latent balance$686,593
P01 · FY2016 · AI · contact PI
Innate Immunity and the HSV lytic/latent balance$681,685
P01 · FY2015 · AI · contact PI
Viral and host factors in herpetic reactivation$396,900
R01 · FY2015 · EY · contact PI
Innate Immunity and the HSV lytic/latent balance$486,000
P01 · FY2014 · AI · contact PI
Viral and host factors in herpetic reactivation$396,900
R01 · FY2014 · EY · contact PI
Innate Immunity and the HSV lytic/latent balance$674,836
P01 · FY2013 · AI · contact PI
Viral and host factors in herpetic reactivation$405,000
R01 · FY2013 · EY · contact PI
Role of HSV Induced RNA Degradation in Pathogenesis$330,144
R01 · FY2013 · EY · contact PI
VIRAL & HOST FACTORS IN HERPETIC REACTIVATION$47,127
R01 · FY2013 · EY · contact PI
VIRAL & HOST FACTORS IN HERPETIC REACTIVATION$47,055
R01 · FY2013 · EY · contact PI
Role of HSV Induced RNA Degradation in Pathogenesis$392,640
R01 · FY2012 · EY · contact PI
VIRAL & HOST FACTORS IN HERPETIC REACTIVATION$375,408
R01 · FY2012 · EY · contact PI
Role of HSV Induced RNA Degradation in Pathogenesis$403,920
R01 · FY2011 · EY · contact PI
VIRAL & HOST FACTORS IN HERPETIC REACTIVATION$375,408
R01 · FY2011 · EY · contact PI
Role of HSV Induced RNA Degradation in Pathogenesis$420,750
R01 · FY2010 · EY · contact PI
VIRAL & HOST FACTORS IN HERPETIC REACTIVATION$391,050
R01 · FY2010 · EY · contact PI
THE IMPACT OF IRF-3-DEPENDENT MECHANISMS ON THE REPLICATION AND VIRULENCE OF HSV$199,867
P20 · FY2010 · RR · contact PI
VIRAL & HOST FACTORS IN HERPETIC REACTIVATION$395,000
R01 · FY2009 · EY · contact PI
Role of HSV Induced RNA Degradation in Pathogenesis$347,250
R01 · FY2009 · EY · contact PI
Role of HSV Induced RNA Degradation in Pathogenesis$90,750
R01 · FY2009 · EY · contact PI
VIRAL & HOST FACTORS IN HERPETIC REACTIVATION$380,000
R01 · FY2008 · EY · contact PI
Viral and host factors in herpetic reactivation$403,816
R01 · FY2007 · EY · contact PI
Viral and host factors in herpetic reactivation$394,264
R01 · FY2006 · EY · contact PI
Role of HSV Induced RNA Degradation in Pathogenesis$298,809
R01 · FY2006 · EY · contact PI
Viral and host factors in herpetic reactivation$391,995
R01 · FY2005 · EY
Role of HSV Induced RNA Degradation in Pathogenesis$306,000
R01 · FY2005 · EY
Viral and host factors in herpetic reactivation$393,826
R01 · FY2004 · EY
Role of HSV Induced RNA Degradation in Pathogenesis$344,250
R01 · FY2004 · EY
Bacterial artificial chromosomes for HSV genomics$153,000
R03 · FY2004 · EY
Role of HSV Induced RNA Degradation in Pathogenesis$344,250
R01 · FY2003 · EY
Bacterial artificial chromosomes for HSV genomics$153,000
R03 · FY2003 · EY
VIRAL AND HOST FACTORS IN HERPETIC REACTIVATION$131,877
R01 · FY2003 · EY
VIRAL AND HOST FACTORS IN HERPETIC REACTIVATION$273,314
R01 · FY2002 · EY
Bacterial artificial chromosomes for HSV genomics$153,000
R03 · FY2002 · EY
VIRAL AND HOST FACTORS IN HERPETIC REACTIVATION$309,915
R01 · FY2001 · EY
HSV INDUCED RNA DEGRADATION AND PATHOGENESIS$263,186
R01 · FY2001 · EY
VIRAL AND HOST FACTORS IN HERPETIC REACTIVATION$9,666
R01 · FY2001 · EY
HSV INDUCED RNA DEGRADATION AND PATHOGENESIS$255,551
R01 · FY2000 · EY
VIRAL AND HOST FACTORS IN HERPETIC REACTIVATION$199,819
R01 · FY2000 · EY